- SR International, Inc. (Phoenix, AZ)
- …in office per week SOAZ - Posting ID # 5743 -AZSLD - Natural Resources Program Specialist/Project Specialist Job Responsibilities *Review and maintain State land ... mineral related spreadsheets, databases, mineral documents and files . *Review monthly billing for accuracy, compliance and processing. *Review and process leases production reports in accordance with lease agreements *Assist in the review and processing of… more
- COOLSOFT (Columbia, SC)
- ADABAS/ Natural CONNX SDLC Audit Management Administrator (Jobs in Columbia, SC) Requirement id 155730 Job title Administrator Job location in Columbia, SC Skills ... required ADABAS/ Natural , CONNX, SDLC, Audit Management Open Date 28-Oct-2025 Close...requirement Job interview type Email Recruiter:coolsoft Job Description Administrator: ADABAS/ Natural , CONNX, SDLC, Audit Management Start date :11/24/2025 End… more
- Expand Energy Corporation (Spring, TX)
- # **Intern \- Natural Gas Scheduling** **Date:** Oct 29, 2025 **Location:** Spring, TX, US, 77389 **Company:** Expand Energy Our core values - Stewardship, ... its large and geographically diverse resource base of unconventional oil and natural gas assets onshore in the United States\. **Nearest Major Market:** Houston… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Merck & Co. (Rahway, NJ)
- …intelligent, agents that empower scientists to query complex datasets using natural language is desired.Experience with incorporating Large Language Models (LLMs) to ... make data and data adjacent tools smarter, and the ability embed LLMs as autonomous agents in our backend processes.Fluency clinical development and experience navigating clinical systems with a strong preference for Veeva CTS.Mastery of tools like Jira and… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Suburban Propane (Whippany, NJ)
- …95 years. We have an exciting opportunity for a **Manager - Renewable Natural Gas Engineering** to be responsible for overseeing the Engineering function of Suburban ... Propane's portfolio of Renewable Natural Gas (RNG) production facilities. In this position you...of Professional Engineering experience required + Experience in Renewable Natural Gas engineering required + Strong project management skills… more
- Legend Biotech USA, Inc. (Philadelphia, PA)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies… more
